{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:38:02Z","timestamp":1791020282293,"version":"4.1.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T00:00:00Z","timestamp":1344902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/nrrheum.2012.120","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T07:40:11Z","timestamp":1344930011000},"page":"587-598","source":"Crossref","is-referenced-by-count":192,"title":["Osteoporosis\u2014a risk factor for cardiovascular disease?"],"prefix":"10.1038","volume":"8","author":[{"given":"Christos E.","family":"Lampropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,14]]},"reference":[{"issue":"Suppl.","key":"BFnrrheum2012120_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster, J. Y. & Burlet, N. Osteoporosis: a still increasing prevalence. Bone 38 (Suppl.), S4\u2013S9 (2006).","journal-title":"Bone"},{"key":"BFnrrheum2012120_CR2","first-page":"193","volume":"79","author":"MG Sweet","year":"2009","unstructured":"Sweet, M. G., Sweet, J.M., Jeremiah, M.P. & Galazka, S. S. Diagnosis and treatment of osteoporosis. Am. Fam. Physician 79, 193\u2013200 (2009).","journal-title":"Am. Fam. Physician"},{"key":"BFnrrheum2012120_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","volume":"367","author":"P Sambrook","year":"2006","unstructured":"Sambrook, P. & Cooper, C. Osteoporosis. Lancet 367, 2010\u20132018 (2006).","journal-title":"Lancet"},{"key":"BFnrrheum2012120_CR4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings, S.R. & Melton, L. J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761\u20131767 (2002).","journal-title":"Lancet"},{"key":"BFnrrheum2012120_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA..107.181425","volume":"115","author":"P Greenland","year":"2007","unstructured":"Greenland, P.  et al. ACCF\/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF\/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 115, 402\u2013426 (2007).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR6","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer, L. L. & Tintut, Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 117, 2938\u20132948 (2008).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","volume":"103","author":"PW Wilson","year":"2001","unstructured":"Wilson, P. W.  et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103, 1529\u20131534 (2001).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bone.2007.07.019","volume":"41","author":"SD Tan","year":"2007","unstructured":"Tan, S. D.  et al. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption. Bone 41, 745\u2013751 (2007).","journal-title":"Bone"},{"key":"BFnrrheum2012120_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","volume":"11","author":"EF Eriksen","year":"2010","unstructured":"Eriksen, E. F. Cellular mechanisms of bone remodeling. Rev. Endocr. Metab. Disord. 11, 219\u2013227 (2010).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"BFnrrheum2012120_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000218336","volume":"76","author":"ZA Radi","year":"2008","unstructured":"Radi, Z. A., Guzman, R. E. & Bell, R. R. Increased connective tissue extracellular matrix in the op\/op model of osteopetrosis. Pathobiology 76, 199\u2013203 (2008).","journal-title":"Pathobiology"},{"key":"BFnrrheum2012120_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum, S. L. Osteoclasts: what do they do and how do they do it? Am. J. Pathol. 170, 427\u2013435 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2012120_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ajcn\/69.1.74","volume":"69","author":"D Feskanich","year":"1999","unstructured":"Feskanich, D.  et al. Vitamin K intake and hip fractures in women: a prospective study. Am. J. Clin. Nutr. 69, 74\u201379 (1999).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum2012120_CR13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1172\/JCI116387","volume":"91","author":"P Szulc","year":"1993","unstructured":"Szulc, P., Chapuy, M. C., Meunier, P. J. & Delmas, P. D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91, 1769\u20131774 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012120_CR14","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1359\/jbmr.2000.15.12.2473","volume":"15","author":"H Luukinen","year":"2000","unstructured":"Luukinen, H.  et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J. Bone Miner. Res. 15, 2473\u20132478 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s002239900543","volume":"63","author":"MH Knapen","year":"1998","unstructured":"Knapen, M. H., Nieuwenhuijzen Kruseman, A. C., Wouters, R. S. & Vermeer, C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif. Tissue Int. 63, 375\u2013379 (1998).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum2012120_CR16","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","volume":"18","author":"GM London","year":"2003","unstructured":"London, G. M.  et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731\u20131740 (2003).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl. A","key":"BFnrrheum2012120_CR17","doi-asserted-by":"publisher","first-page":"A57","DOI":"10.1016\/j.jvs.2007.02.049","volume":"45","author":"RJ Guzman","year":"2007","unstructured":"Guzman, R. J. Clinical, cellular and molecular aspects of arterial calcification. J. Vasc. Surg. 45 (Suppl. A), A57\u2013A63 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrrheum2012120_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.111.187807","volume":"59","author":"ER Smith","year":"2012","unstructured":"Smith, E. R.  et al. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 59, 973\u2013978 (2012).","journal-title":"Hypertension"},{"key":"BFnrrheum2012120_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1540-8175.2006.00300.x","volume":"23","author":"HJ Willens","year":"2006","unstructured":"Willens, H. J.  et al. The relation between mitral annular calcification and mortality in patients undergoing diagnostic coronary angiography. Echocardiography 23, 717\u2013722 (2006).","journal-title":"Echocardiography"},{"key":"BFnrrheum2012120_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1159\/000332221","volume":"34","author":"EA Ross","year":"2011","unstructured":"Ross, E. A. Evolution of treatment strategies for calciphylaxis. Am. J. Nephrol. 34, 460\u2013467 (2011).","journal-title":"Am. J. Nephrol."},{"key":"BFnrrheum2012120_CR21","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","volume":"111","author":"P Libby","year":"2005","unstructured":"Libby, P. & Theroux P. Pathophysiology of coronary artery disease. Circulation 111, 3481\u20133488 (2005).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.109.134205","volume":"55","author":"JS Shao","year":"2010","unstructured":"Shao, J. S., Cheng, S. L., Sadhu, J. & Towler, D. A. Inflammation and the osteogenic regulation of vascular calcification: a review & perspective. Hypertension 55, 579\u2013592 (2010).","journal-title":"Hypertension"},{"key":"BFnrrheum2012120_CR23","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1152\/ajpheart.00455.2009","volume":"297","author":"R Nakano-Kurimoto","year":"2009","unstructured":"Nakano-Kurimoto, R.  et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am. J. Physiol. Heart Circ. Physiol. 297, 1673\u20131684 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrrheum2012120_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1152\/ajpendo.00552.2003","volume":"286","author":"R Vattikuti","year":"2004","unstructured":"Vattikuti, R. & Towler, D. A. Osteogenic regulation of vascular calcification: an early perspective. Am. J. Physiol. Endocrinol. Metab. 286, 686\u2013696 (2004).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrrheum2012120_CR25","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","volume":"107","author":"NM Rajamannan","year":"2003","unstructured":"Rajamannan, N. M.  et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107, 2181\u20132184 (2003).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR26","first-page":"1547","volume":"114","author":"L Osman","year":"2006","unstructured":"Osman, L., Yacoub, M. H., Latif, N., Amrani, M. & Chester, A. H. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 114, 1547\u20131552 (2006).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR27","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1161\/01.CIR.0000144457.55518.E5","volume":"110","author":"C Farrington-Rock","year":"2004","unstructured":"Farrington-Rock, C.  et al. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 110, 2226\u20132232 (2004).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1365-2362.2010.02275.x","volume":"40","author":"RJ Rennenberg","year":"2010","unstructured":"Rennenberg, R. J.  et al. Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur. J. Clin. Invest. 40, 344\u2013349 (2010).","journal-title":"Eur. J. Clin. Invest."},{"key":"BFnrrheum2012120_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1210\/endo.140.2.6493","volume":"140","author":"E Gazzerro","year":"1999","unstructured":"Gazzerro, E., Rydziel, S. & Canalis, E. Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts. Endocrinology 140, 562\u2013567 (1999).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012120_CR30","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1210\/endo.138.7.5125","volume":"138","author":"SD Boden","year":"1997","unstructured":"Boden, S. D.  et al. Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 138, 2820\u20132828 (1997).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012120_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2353\/ajpath.2006.050284","volume":"168","author":"A Csiszar","year":"2006","unstructured":"Csiszar, A.  et al. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am. J. Pathol. 168, 629\u2013638 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2012120_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/01.ATV.0000061735.85377.40","volume":"23","author":"Z Ungvari","year":"2003","unstructured":"Ungvari, Z.  et al. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-\u03b1, NAD(P)H oxidase and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 23, 418\u2013424 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR33","doi-asserted-by":"publisher","first-page":"30427","DOI":"10.1074\/jbc.273.46.30427","volume":"273","author":"DA Towler","year":"1998","unstructured":"Towler, D. A., Bidder, M., Latifi, T., Coleman, T. & Semenkovich, C. F. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J. Biol. Chem. 273, 30427\u201330434 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012120_CR34","doi-asserted-by":"publisher","first-page":"H569","DOI":"10.1152\/ajpheart.00180.2008","volume":"295","author":"A Csiszar","year":"2008","unstructured":"Csiszar, A., Labinskyy, N., Jo, H., Ballabh, P. & Ungvari, Z. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 295, H569\u2013H577 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrrheum2012120_CR35","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1681\/ASN.2007070760","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew, S.  et al. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J. Am. Soc. Nephrol. 19, 1092\u20131105 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrrheum2012120_CR36","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/jcp.20770","volume":"209","author":"KH Szymczyk","year":"2006","unstructured":"Szymczyk, K. H., Freeman, T. A., Adams, C. S., Srinivas, V. & Steinbeck, M. J. Active caspase-3 is required for osteoclast differentiation. J. Cell. Physiol. 209, 836\u2013844 (2006).","journal-title":"J. Cell. Physiol."},{"key":"BFnrrheum2012120_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1210\/er.2007-0014","volume":"29","author":"AE Kearns","year":"2008","unstructured":"Kearns, A. E., Khosla, S. & Kostenuik, P. J. Receptor activator of nuclear factor \u03baB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29, 155\u2013192 (2008).","journal-title":"Endocr. Rev."},{"key":"BFnrrheum2012120_CR38","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1359\/jbmr.2001.16.12.2205","volume":"16","author":"T Sobue","year":"2001","unstructured":"Sobue, T.  et al. Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J. Bone Miner. Res. 16, 2205\u20132214 (2001).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR39","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","volume":"140","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer, L. C.  et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140, 4367\u20134370 (1999).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012120_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1161\/01.ATV.0000204334.48195.6a","volume":"26","author":"WJ Sandberg","year":"2006","unstructured":"Sandberg, W. J.  et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler. Thromb. Vasc. Biol. 26, 857\u2013863 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.106.686774","volume":"116","author":"S Kiechl","year":"2007","unstructured":"Kiechl, S.  et al. Soluble receptor activator of nuclear factor-\u03baB ligand and risk for cardiovascular disease. Circulation 116, 385\u2013391 (2007).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR42","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.atherosclerosis.2008.10.024","volume":"204","author":"M Shargorodsky","year":"2009","unstructured":"Shargorodsky, M.  et al. Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. Atherosclerosis 204, 608\u2013611 (2009).","journal-title":"Atherosclerosis"},{"key":"BFnrrheum2012120_CR43","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","volume":"109","author":"S Kiechl","year":"2004","unstructured":"Kiechl, S.  et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109, 2175\u20132180 (2004).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR44","first-page":"631","volume":"86","author":"WS Browner","year":"2001","unstructured":"Browner, W. S., Lui, L. Y. & Cummings, S. R. Association of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures and mortality in elderly women. J. Clin. Endocrinol. Metab. 86, 631\u2013637 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum2012120_CR45","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","volume":"273","author":"JG Emery","year":"1998","unstructured":"Emery, J. G.  et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J. Biol. Chem. 273, 14363\u201314367 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012120_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","volume":"117","author":"S Morony","year":"2008","unstructured":"Morony, S.  et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in Ldlr(\u2212\/\u2212) mice. Circulation 117, 411\u2013420 (2008).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR47","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan, V., Bryant, H. U. & MacDougald, O. A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116, 1202\u20131209 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012120_CR48","doi-asserted-by":"publisher","first-page":"10890","DOI":"10.1074\/jbc.M807994200","volume":"284","author":"V Veverka","year":"2009","unstructured":"Veverka V.  et al. Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation. J. Biol. Chem. 284, 10890\u201310900 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012120_CR49","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3324\/haematol.2008.000893","volume":"94","author":"E Voskaridou","year":"2009","unstructured":"Voskaridou E.  et al. Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. Haematologica 94, 725\u2013728 (2009).","journal-title":"Haematologica"},{"key":"BFnrrheum2012120_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bone.2006.09.004","volume":"40","author":"FS Wang","year":"2007","unstructured":"Wang F. S.  et al. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss: a histomorphological study in ovariectomized rats. Bone 40, 485\u2013492 (2007).","journal-title":"Bone"},{"key":"BFnrrheum2012120_CR51","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/ijc.22033","volume":"119","author":"M Politou","year":"2006","unstructured":"Politou, M.  et al. Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation. Int. J. Cancer 119, 1728\u20131731 (2006).","journal-title":"Int. J. Cancer"},{"key":"BFnrrheum2012120_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","volume":"97","author":"N Voorzanger-Rousselot","year":"2007","unstructured":"Voorzanger-Rousselot, N.  et al. Increased Dickkopf-1 expression in breast cancer bone metastases. Br. J. Cancer 97, 964\u2013970 (2007).","journal-title":"Br. J. Cancer"},{"key":"BFnrrheum2012120_CR53","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/art.23454","volume":"58","author":"W Yao","year":"2008","unstructured":"Yao, W.  et al. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum. 58, 1674\u20131686 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2012120_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbrc.2005.01.117","volume":"329","author":"K Ohnaka","year":"2005","unstructured":"Ohnaka, K., Tanabe, M., Kawate, H., Nawata, H. & Takayanagi, R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun. 329, 177\u2013181 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum2012120_CR55","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1210\/en.2006-0459","volume":"147","author":"D Jia","year":"2006","unstructured":"Jia, D., O'Brien, C. A., Stewart, S. A., Manolagas, S. C. & Weinstein, R. S. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147, 5592\u20135599 (2006).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012120_CR56","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI24140","volume":"115","author":"JS Shao","year":"2005","unstructured":"Shao, J. S.  et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J. Clin. Invest. 115, 1210\u20131220 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2012120_CR57","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","volume":"361","author":"M Ketteler","year":"2003","unstructured":"Ketteler, M.  et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361, 827\u2013833 (2003).","journal-title":"Lancet"},{"key":"BFnrrheum2012120_CR58","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.106.682450","volume":"115","author":"JH Ix","year":"2007","unstructured":"Ix, J. H.  et al. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115, 2533\u20132539 (2007).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR59","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jcb.22124","volume":"107","author":"S Suttamanatwong","year":"2009","unstructured":"Suttamanatwong, S.  et al. Sp proteins and Runx2 mediate regulation of matrix Gla protein (MGP) expression by parathyroid hormone. J. Cell. Biochem. 107, 284\u2013292 (2009).","journal-title":"J. Cell. Biochem."},{"key":"BFnrrheum2012120_CR60","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1038\/sj.emboj.7600282","volume":"23","author":"R Eferl","year":"2004","unstructured":"Eferl, R.  et al. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789\u20132799 (2004).","journal-title":"EMBO J."},{"key":"BFnrrheum2012120_CR61","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1160\/TH03-08-0572","volume":"91","author":"S Jono","year":"2004","unstructured":"Jono, S.  et al. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb. Haemost. 91, 790\u2013794 (2004).","journal-title":"Thromb. Haemost."},{"key":"BFnrrheum2012120_CR62","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2796.2010.02264.x","volume":"268","author":"T Ueland","year":"2010","unstructured":"Ueland, T.  et al. Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J. Intern. Med. 268, 483\u2013492 (2010).","journal-title":"J. Intern. Med."},{"key":"BFnrrheum2012120_CR63","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2215\/CJN.07081009","volume":"5","author":"LJ Schurgers","year":"2010","unstructured":"Schurgers, L. J.  et al. The circulating inactive form of matrix Gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin. J. Am. Soc. Nephrol. 5, 568\u2013575 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrrheum2012120_CR64","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/CIRCRESAHA.110.216846","volume":"107","author":"MK Osako","year":"2010","unstructured":"Osako, M. K.  et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ. Res. 107, 466\u2013475 (2010).","journal-title":"Circ. Res."},{"key":"BFnrrheum2012120_CR65","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JME-11-0145","volume":"48","author":"JR Nofer","year":"2012","unstructured":"Nofer, J. R. Estrogens and atherosclerosis: insights from animal models and cell systems. J. Mol. Endocrinol. 48, R13\u2013R29 (2012).","journal-title":"J. Mol. Endocrinol."},{"key":"BFnrrheum2012120_CR66","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1253\/circj.71.1555","volume":"71","author":"H Sumino","year":"2007","unstructured":"Sumino, H.  et al. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circ. J. 71, 1555\u20131559 (2007).","journal-title":"Circ. J."},{"key":"BFnrrheum2012120_CR67","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ajcn\/77.2.512","volume":"77","author":"SL Booth","year":"2003","unstructured":"Booth, S. L.  et al. Vitamin K intake and bone mineral density in women and men. Am. J. Clin. Nutr. 77, 512\u2013516 (2003).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum2012120_CR68","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1210\/jcem-60-6-1268","volume":"60","author":"JP Hart","year":"1985","unstructured":"Hart, J. P.  et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab. 60, 1268\u20131269 (1985).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum2012120_CR69","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/jbmr.5650081012","volume":"8","author":"SJ Hodges","year":"1993","unstructured":"Hodges, S. J, Akesson, K., Vergnaud, P., Obrant, K. & Delmas, P. D. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J. Bone Miner. Res. 8, 1241\u20131245 (1993).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR70","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000124863","volume":"45","author":"EC Cranenburg","year":"2008","unstructured":"Cranenburg, E. C.  et al. The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification. J. Vasc. Res. 45, 427\u2013436 (2008).","journal-title":"J. Vasc. Res."},{"key":"BFnrrheum2012120_CR71","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1093\/jn\/134.11.3100","volume":"134","author":"JM Geleijnse","year":"2004","unstructured":"Geleijnse, J. M.  et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J. Nutr. 134, 3100\u20133105 (2004).","journal-title":"J. Nutr."},{"key":"BFnrrheum2012120_CR72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.numecd.2008.10.004","volume":"19","author":"GC Gast","year":"2009","unstructured":"Gast, G. C.  et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 19, 504\u2013510 (2009).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"BFnrrheum2012120_CR73","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3945\/ajcn.2008.27338","volume":"89","author":"MK Shea","year":"2009","unstructured":"Shea, M. K.  et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am. J. Clin. Nutr. 89, 1799\u20131807 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrrheum2012120_CR74","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","volume":"336","author":"MJ Bolland","year":"2008","unstructured":"Bolland, M. J.  et al. Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ 336, 262\u2013266 (2008).","journal-title":"BMJ"},{"key":"BFnrrheum2012120_CR75","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1182\/blood-2004-04-1277","volume":"104","author":"LJ Schurgers","year":"2004","unstructured":"Schurgers, L. J., Aebert, H., Vermeer, C., B\u00fcltmann, B. & Janzen, J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 104, 3231\u20133232 (2004).","journal-title":"Blood"},{"key":"BFnrrheum2012120_CR76","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.ATV.18.9.1400","volume":"18","author":"PA Price","year":"1998","unstructured":"Price, P. A., Faus, S. A. & Williamson, M. K. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 18, 1400\u20131407 (1998).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR77","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"KA Hruska","year":"2008","unstructured":"Hruska, K. A., Mathew, S., Lund, R., Qiu, P. & Pratt, R. Hyperphosphatemia of chronic kidney disease. Kidney Int. 74, 148\u2013157 (2008).","journal-title":"Kidney Int."},{"key":"BFnrrheum2012120_CR78","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstr\u00f6m","year":"2009","unstructured":"Hagstr\u00f6m, E.  et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119, 2765\u20132771 (2009).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR79","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li, X., Yang, H. Y. & Giachelli, C. M. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ. Res. 98, 905\u2013912 (2006).","journal-title":"Circ. Res."},{"key":"BFnrrheum2012120_CR80","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar1461","volume":"7","author":"M Skoumal","year":"2005","unstructured":"Skoumal, M.  et al. Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction. Arthritis Res. Ther. 7, R65\u2013R70 (2005).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2012120_CR81","doi-asserted-by":"publisher","unstructured":"Perez-Castrillon, J. L., Pinacho, F., De Luis, D., Lopez-Menendez, M. & Laita, A. D. Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women. J. Osteoporos. \n                    http:\/\/dx.doi.org\/10.4061\/2010\/401581\n                    \n                  .","DOI":"10.4061\/2010\/401581"},{"key":"BFnrrheum2012120_CR82","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.107.688523","volume":"115","author":"S Kitamoto","year":"2007","unstructured":"Kitamoto, S.  et al. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115, 2065\u20132075 (2007).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR83","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","volume":"113","author":"E Lutgens","year":"2006","unstructured":"Lutgens, E.  et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113, 98\u2013107 (2006).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR84","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1210\/endo.142.3.8006","volume":"142","author":"Y Asou","year":"2001","unstructured":"Asou, Y.  et al. Osteoponotin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142, 1325\u20131332 (2001).","journal-title":"Endocrinology"},{"key":"BFnrrheum2012120_CR85","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","volume":"27","author":"M Scatena","year":"2007","unstructured":"Scatena, M., Liaw, L. & Giachelli, C. M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27, 2302\u20132309 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR86","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20020911","volume":"196","author":"MY Speer","year":"2002","unstructured":"Speer, M. Y.  et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J. Exp. Med. 196, 1047\u20131055 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2012120_CR87","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jvs.2007.09.058","volume":"47","author":"NP Kadoglou","year":"2008","unstructured":"Kadoglou, N. P.  et al. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. J. Vasc. Surg. 47, 55\u201362 (2008).","journal-title":"J. Vasc. Surg."},{"key":"BFnrrheum2012120_CR88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","volume":"84","author":"T Wada","year":"1999","unstructured":"Wada, T., McKee, M. D., Steitz, S. & Giachelli, C. M. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ. Res. 84, 166\u2013178 (1999).","journal-title":"Circ. Res."},{"key":"BFnrrheum2012120_CR89","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1254\/jphs.FM0070218","volume":"106","author":"A Suzuki","year":"2008","unstructured":"Suzuki, A., Sekiguchi, S., Asano, S. & Itoh, M. Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis. J. Pharmacol. Sci. 106, 530\u2013535 (2008).","journal-title":"J. Pharmacol. Sci."},{"key":"BFnrrheum2012120_CR90","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.bbrc.2008.07.062","volume":"374","author":"MS Huang","year":"2008","unstructured":"Huang, M. S., Sage, A. P., Lu, J., Demer, L. L. & Tintut, Y. Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem. Biophys. Res. Commun. 374, 553\u2013558 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum2012120_CR91","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1161\/01.CIR.102.21.2636","volume":"102","author":"Y Tintut","year":"2000","unstructured":"Tintut, Y., Patel, J., Parhami, F. & Demer, L. L. Tumor necrosis factor-\u03b1 promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102, 2636\u20132642 (2000).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR92","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1074\/jbc.273.13.7547","volume":"273","author":"Y Tintut","year":"1998","unstructured":"Tintut, Y., Parhami, F., Bostr\u00f6m, K., Jackson, S. M. & Demer, L. L. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells: potential signaling pathway for vascular calcification. J. Biol. Chem. 273, 7547\u20137553 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum2012120_CR93","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.ki.5002406","volume":"72","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi, M., Finch, J. L., Martin, D. R. & Slatopolsky, E. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int. 72, 709\u2013715 (2007).","journal-title":"Kidney Int."},{"key":"BFnrrheum2012120_CR94","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1359\/JBMR.051211","volume":"21","author":"A Bas","year":"2006","unstructured":"Bas, A., Lopez, I., Perez, J., Rodriguez, M. & Aquilera-Tejero, E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J. Bone Miner. Res. 21, 484\u2013490 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR95","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/01.CIR.92.8.2029","volume":"92","author":"LL Demer","year":"1995","unstructured":"Demer, L. L. A skeleton in the atherosclerosis closet. Circulation 92, 2029\u20132032 (1995).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR96","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","volume":"111","author":"D Somjen","year":"2005","unstructured":"Somjen, D.  et al. 25-hydroxyvitamin D3-1\u03b1-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111, 1666\u20131671 (2005).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR97","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/jbmr.2001.16.1.182","volume":"16","author":"F Parhami","year":"2001","unstructured":"Parhami, F.  et al. Atherogenic high-fat diet reduces bone mineralization in mice. J. Bone Miner. Res. 16, 182\u2013188 (2001).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR98","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1161\/01.ATV.20.11.2346","volume":"20","author":"F Parhami","year":"2000","unstructured":"Parhami, F., Garfinkel, A. & Demer, L. L. Role of lipids in osteoporosis. Arterioscler. Thromb. Vasc. Biol. 20, 2346\u20132348 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR99","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/01.ATV.0000112023.62695.7f","volume":"24","author":"Y Tintut","year":"2004","unstructured":"Tintut, Y., Morony, S. & Demer, L. L. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler. Thromb. Vasc. Biol. 24, 6\u201310 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR100","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","volume":"17","author":"F Parhami","year":"1997","unstructured":"Parhami, F.  et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17, 680\u2013687 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1507\/endocrj.49.211","volume":"49","author":"T Yamaguchi","year":"2002","unstructured":"Yamaguchi, T.  et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr. J. 49, 211\u2013217 (2002).","journal-title":"Endocr. J."},{"key":"BFnrrheum2012120_CR102","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","volume":"286","author":"G Mundy","year":"1999","unstructured":"Mundy, G.  et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286, 1946\u20131949 (1999).","journal-title":"Science"},{"key":"BFnrrheum2012120_CR103","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","volume":"355","author":"CJ Edwards","year":"2000","unstructured":"Edwards, C. J., Hart, D. J. & Spector, T. D. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355, 2218\u20132219 (2000).","journal-title":"Lancet"},{"key":"BFnrrheum2012120_CR104","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1001\/jama.283.24.3205","volume":"283","author":"CR Meier","year":"2000","unstructured":"Meier, C. R., Schlienger, R. G., Kraenzlin, M. E., Schlegel, B. & Jick, H. HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283, 3205\u20133210 (2000).","journal-title":"JAMA"},{"key":"BFnrrheum2012120_CR105","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1365-2265.2008.03176.x","volume":"68","author":"Y Shapiro","year":"2008","unstructured":"Shapiro, Y., Boaz, M., Matas, Z., Fux, A. & Shargorodsky, M. The association between the rennin\u2013angiotensin\u2013aldosterone system and arterial stiffness in young healthy subjects. Clin. Endocrinol. (Oxf.) 68, 510\u2013512 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrrheum2012120_CR106","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu, H.  et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 22, 2465\u20132475 (2008).","journal-title":"FASEB J."},{"key":"BFnrrheum2012120_CR107","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","volume":"46","author":"PH Law","year":"2005","unstructured":"Law, P. H., Sun, Y., Bhattacharya, S. K., Chhokar, V. S. & Weber, K. T. Diuretics and bone loss in rats with aldosteronism. J. Am. Coll. Cardiol. 46, 142\u2013146 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrrheum2012120_CR108","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"Lynn, H., Kwok, T., Wong, S. Y., Woo, J. & Leung, P. C. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38, 584\u2013588 (2006).","journal-title":"Bone"},{"key":"BFnrrheum2012120_CR109","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.ATV.21.5.817","volume":"21","author":"PA Price","year":"2001","unstructured":"Price, P. A., Faus, S. A. & Williamson, M. K. Biphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler. Thromb. Vasc. Biol. 21, 817\u2013824 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR110","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman, S. P.  et al. Nitrogen-containing biphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J. Bone Miner. Res. 13, 581\u2013589 (1998).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1043-6618(02)00041-5","volume":"46","author":"JZ Su","year":"2002","unstructured":"Su, J. Z., Fukuda, N., Kishioka, H., Hu, W. Y. & Kanmatsuse, K. Etidronate influences growth and phenotype of rat vascular smooth muscle cells. Pharmacol. Res. 46, 7\u201313 (2002).","journal-title":"Pharmacol. Res."},{"key":"BFnrrheum2012120_CR112","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/MAJ.0b013e3181db6dfe","volume":"339","author":"I Kanazawa","year":"2010","unstructured":"Kanazawa, I.  et al. Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis. Am. J. Med. Sci. 339, 519\u2013524 (2010).","journal-title":"Am. J. Med. Sci."},{"key":"BFnrrheum2012120_CR113","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1359\/jbmr.080504","volume":"23","author":"JT Chow","year":"2008","unstructured":"Chow, J. T.  et al. Abdominal aortic calcification, BMD, and bone microstructure: a population-based study. J. Bone Miner. Res. 23, 1601\u20131612 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR114","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/aje\/kwn303","volume":"169","author":"JA Hyder","year":"2009","unstructured":"Hyder, J. A.  et al. Association of coronary artery and aortic calcium with lumbar bone density. The MESA Abdominal Aortic Calcium Study. Am. J. Epidemiol. 169, 186\u2013194 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrrheum2012120_CR115","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2265.2009.03535.x","volume":"71","author":"SH Choi","year":"2009","unstructured":"Choi, S. H.  et al. Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin. Endocrinol. 71, 644\u2013651 (2009).","journal-title":"Clin. Endocrinol."},{"key":"BFnrrheum2012120_CR116","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1161\/01.ATV.20.8.1926","volume":"20","author":"AE Hak","year":"2000","unstructured":"Hak, A. E., Pols, H. A., van Hemert, A. M., Hofman, A. & Witteman, J. C. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler. Thromb. Vasc. Biol. 20, 1926\u20131931 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrrheum2012120_CR117","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2215\/CJN.01870408","volume":"4","author":"T Adragao","year":"2009","unstructured":"Adragao, T.  et al. Low bone volume\u2014a risk factor for coronary calcifications in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 4, 350\u2013455 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrrheum2012120_CR118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00223-002-2070-x","volume":"73","author":"LB Tanko","year":"2003","unstructured":"Tanko, L. B., Bagger, Y. Z. & Christiansen, C. Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif. Tissue Int. 73, 15\u201320 (2003).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum2012120_CR119","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1210\/jc.2007-0693","volume":"93","author":"J Reddy","year":"2008","unstructured":"Reddy, J., Bilezikian, J. P., Smith, S. J. & Mosca, L. Reduced bone mineral density is associated with breast arterial calcification. J. Clin. Endocrinol. Metab. 93, 208\u2013211 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum2012120_CR120","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1161\/01.STR.28.9.1730","volume":"28","author":"O Uyama","year":"1997","unstructured":"Uyama, O., Yoshimoto, Y., Yamamoto, Y. & Kawai, A. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28, 1730\u20131732 (1997).","journal-title":"Stroke"},{"key":"BFnrrheum2012120_CR121","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1291\/hypres.31.1191","volume":"31","author":"H Sumino","year":"2008","unstructured":"Sumino, H.  et al. Relationship between carotid atherosclerosis and lumbar spine bone mineral density in postmenopausal women. Hypertens. Res. 31, 1191\u20131197 (2008).","journal-title":"Hypertens. Res."},{"key":"BFnrrheum2012120_CR122","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1253\/circj.71.1555","volume":"71","author":"H Sumino","year":"2007","unstructured":"Sumino, H.  et al. Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women. Circ. J. 71, 1555\u20131559 (2007).","journal-title":"Circ. J."},{"key":"BFnrrheum2012120_CR123","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/gme.0b013e3181a15552","volume":"16","author":"SK Seo","year":"2009","unstructured":"Seo, S. K.  et al. Bone mineral density, arterial stiffness and coronary atherosclerosis in healthy postmenopausal women. Menopause 16, 937\u2013943 (2009).","journal-title":"Menopause"},{"key":"BFnrrheum2012120_CR124","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1359\/jbmr.070903","volume":"23","author":"P Szulc","year":"2008","unstructured":"Szulc, P., Kiel, D. P. & Delmas, P. D. Calcifications in the abdominal aorta depicts fractures in men: MINOS study. J. Bone Miner. Res. 23, 95\u2013102 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR125","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1210\/jc.2003-030964","volume":"89","author":"E Schulz","year":"2004","unstructured":"Schulz, E., Arfai, K., Liu, X., Sayre, J. & Gilsanz, V. Aortic calcification and the risk of osteoporosis and fractures. J. Clin. Endocrinol. Metab. 89, 4246\u20134253 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrrheum2012120_CR126","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1365-2796.2006.01640.x","volume":"259","author":"YZ Bagger","year":"2006","unstructured":"Bagger, Y. Z., Tanko, L. B., Alexandersen, P., Qin, G. & Christiansen, C. Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J. Intern. Med. 259, 598\u2013605 (2006).","journal-title":"J. Intern. Med."},{"key":"BFnrrheum2012120_CR127","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00198-007-0539-1","volume":"19","author":"M Naves","year":"2008","unstructured":"Naves, M., Rodriguez-Garcia, M., Diaz-Lopez, J. B., Gomez-Alonso, C. & Cannata-Andia, J. B. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos. Int. 19, 1161\u20131166 (2008).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum2012120_CR128","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1359\/jbmr.070519","volume":"22","author":"EJ Samelson","year":"2007","unstructured":"Samelson, E. J.  et al. Vascular calcification in middle-age and long term risk of hip fracture: the Framingham Study. J. Bone Miner. Res. 22, 1449\u20131454 (2007).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR129","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00198-007-0338-8","volume":"18","author":"GN Farhat","year":"2007","unstructured":"Farhat, G. N.  et al. The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos. Int. 18, 999\u20131008 (2007).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum2012120_CR130","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00223-006-0052-0","volume":"79","author":"GN Farhat","year":"2006","unstructured":"Farhat, G. N.  et al. Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging and body composition study. Calcif. Tissue Int. 79, 102\u2013111 (2006).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum2012120_CR131","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s001980170114","volume":"12","author":"DP Trivedi","year":"2001","unstructured":"Trivedi, D. P. & Khaw, K. T. Bone mineral density at the hip predicts mortality in elderly men. Osteoporos. Int. 12, 259\u2013265 (2001).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum2012120_CR132","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/01.STR.32.1.47","volume":"32","author":"L Jorgensen","year":"2001","unstructured":"Jorgensen, L., Engstad, T. & Jacobsen, B. Bone mineral density in acute stroke patients, low bone mineral density may predict first stroke in women. Stroke 32, 47\u201351 (2001).","journal-title":"Stroke"},{"key":"BFnrrheum2012120_CR133","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF02390833","volume":"68","author":"DP Kiel","year":"2001","unstructured":"Kiel, D. P.  et al. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif. Tissue Int. 68, 271\u2013276 (2001).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrrheum2012120_CR134","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.amjcard.2005.06.034","volume":"96","author":"PA Marcovitz","year":"2005","unstructured":"Marcovitz, P. A.  et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am. J. Cardiol. 96, 1059\u20131063 (2005).","journal-title":"Am. J. Cardiol."},{"key":"BFnrrheum2012120_CR135","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1359\/JBMR.050711","volume":"20","author":"LB Tanko","year":"2005","unstructured":"Tanko, L. B.  et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J. Bone Miner. Res. 20, 1912\u20131920 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR136","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ndt\/gfn466","volume":"24","author":"M Rodriguez-Garcia","year":"2009","unstructured":"Rodriguez-Garcia, M.  et al. Vascular calcifications, vertebral fractures and mortality in haemodiaysis patients. Nephrol. Dial. Transplant. 24, 239\u2013246 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrrheum2012120_CR137","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1161\/CIRCULATIONAHA.108.820993","volume":"119","author":"TC Collins","year":"2009","unstructured":"Collins, T. C.  et al. Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation 119, 2305\u20132312 (2009).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR138","first-page":"103","volume":"21","author":"M Laroche","year":"2003","unstructured":"Laroche, M.  et al. Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease. Clin. Exp. Rheumatol. 21, 103\u2013106 (2003).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2012120_CR139","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00198-003-1550-9","volume":"15","author":"P Pennisi","year":"2004","unstructured":"Pennisi, P.  et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos. Int. 15, 389\u2013395 (2004).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum2012120_CR140","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1359\/jbmr.1997.12.2.283","volume":"12","author":"MT Vogt","year":"1997","unstructured":"Vogt, M. T., Cauley, J. A., Kuller, L. H. & Nevitt, M. C. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J. Bone Miner. Res. 12, 283\u2013289 (1997).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR141","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00198-005-1968-3","volume":"16","author":"SY Wong","year":"2005","unstructured":"Wong, S. Y.  et al. Bone mineral density and the risk of peripheral arterial disease in men and women: results from Mr and Ms Os, Hong Kong. Osteoporos. Int. 16, 1933\u20131938 (2005).","journal-title":"Osteoporos. Int."},{"key":"BFnrrheum2012120_CR142","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1161\/CIRCULATIONAHA.108.784009","volume":"118","author":"S van Diepen","year":"2008","unstructured":"van Diepen, S., Majumdar, S. R., Bakal, J. A., McAlister, F. A. & Ezekowitz, J. A. Heart failure is a risk factor for orthopaedic fracture: a population-based analysis of 16,294 patients. Circulation 118, 1946\u20131952 (2008).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR143","doi-asserted-by":"publisher","first-page":"d2040","DOI":"10.1136\/bmj.d2040","volume":"342","author":"MJ Bolland","year":"2011","unstructured":"Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D. & Reid, I. R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342, d2040 (2011).","journal-title":"BMJ"},{"key":"BFnrrheum2012120_CR144","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.106.673491","volume":"115","author":"J Hsia","year":"2007","unstructured":"Hsia, J.  et al. Calcium\/vitamin D supplementation and cardiovascular events. Circulation 115, 846\u2013854 (2007).","journal-title":"Circulation"},{"key":"BFnrrheum2012120_CR145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jbmr.176","volume":"26","author":"JR Lewis","year":"2011","unstructured":"Lewis, J. R., Calver, J., Zhu, K., Flicker, L. & Prince, R. L. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J. Bone Miner. Res. 26, 35\u201341 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR146","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1002\/jbmr.183","volume":"25","author":"TK Wang","year":"2010","unstructured":"Wang, T. K.  et al. Relationships between vascular calcification, calcium metabolism, bone density, and fractures. J. Bone Miner. Res. 25, 2777\u20132785 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrrheum2012120_CR147","doi-asserted-by":"publisher","first-page":"c3691","DOI":"10.1136\/bmj.c3691","volume":"341","author":"MJ Bolland","year":"2010","unstructured":"Bolland, M. J.  et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691 (2010).","journal-title":"BMJ"},{"key":"BFnrrheum2012120_CR148","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","volume":"336","author":"MJ Bolland","year":"2008","unstructured":"Bolland, M. J.  et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336, 262\u2013266 (2008).","journal-title":"BMJ"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2012.120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:29:56Z","timestamp":1684456196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2012.120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,14]]},"references-count":148,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFnrrheum2012120"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2012.120","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,14]]}}}